{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:34:51Z","timestamp":1762508091255,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jdcr.2020.03.002","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T14:46:13Z","timestamp":1588171573000},"page":"386-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Erythema multiforme after initiation of anti interleukin-12\/23 (ustekinumab) treatment for plaque psoriasis"],"prefix":"10.1016","volume":"6","author":[{"given":"Martina","family":"Burlando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia Fabio","family":"Molle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara Trambaiolo","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Cozzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2020.03.002_bib1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2020.03.002_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11538950-000000000-00000","article-title":"New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab","volume":"12","author":"Kurzeja","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"9664","key":"10.1016\/j.jdcr.2020.03.002_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","article-title":"Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial","volume":"373","author":"Gottlieb","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jdcr.2020.03.002_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist","volume":"51","author":"Sokumbi","year":"2012","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2020.03.002_bib5","doi-asserted-by":"crossref","first-page":"e12847","DOI":"10.1111\/dth.12847","article-title":"Erythema multiforme: differences between HSV-1 and HSV-2 and management of the disease-a case report and mini review","volume":"32","author":"Magri","year":"2019","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.jdcr.2020.03.002_bib6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaad.2009.04.048","article-title":"Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis","volume":"62","author":"Ahdout","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2020.03.002_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/1153420-S0-000000000-00000","article-title":"Adverse effects of biological agents in the treatment of psoriasis","volume":"11","author":"Rongioletti","year":"2010","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2020.03.002_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14740338.2017.1323864","article-title":"The safety of ustekinumab for the treatment of psoriatic arthritis","volume":"16","author":"L\u00f3pez-Ferrer","year":"2017","journal-title":"Expert Opin Drug Saf"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620302113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620302113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:21:21Z","timestamp":1762474881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512620302113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2352512620302113"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.03.002","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythema multiforme after initiation of anti interleukin-12\/23 (ustekinumab) treatment for plaque psoriasis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}